Edward White
Stock Analyst at HC Wainwright & Co.
(1.77)
# 3,156
Out of 4,876 analysts
372
Total ratings
25.36%
Success rate
-8.56%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $7.80 | +323.08% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $5.75 | +195.65% | 41 | Apr 15, 2025 | |
| INZY Inozyme Pharma | Reiterates: Buy | $16 | $4.00 | +300.50% | 14 | Apr 10, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $7.49 | +100.27% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $1.78 | +237.85% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $2.17 | +637.33% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.59 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $8.61 | +829.69% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $2.35 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $1.57 | +1,173.89% | 2 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $5.66 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $2.96 | +441.46% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $6.28 | +298.41% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.83 | +863.86% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.60 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $0.67 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $36.68 | +49.95% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $9.13 | +458.60% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.29 | +112.77% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $4.35 | +1,187.36% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $9.84 | +215.04% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.02 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $0.31 | +8,848.55% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $21.64 | +38.63% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.05 | +1,048.33% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $7.80
Upside: +323.08%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $5.75
Upside: +195.65%
Inozyme Pharma
Apr 10, 2025
Reiterates: Buy
Price Target: $16
Current: $4.00
Upside: +300.50%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $7.49
Upside: +100.27%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $1.78
Upside: +237.85%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $2.17
Upside: +637.33%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.59
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $8.61
Upside: +829.69%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.35
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $1.57
Upside: +1,173.89%
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.66
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $2.96
Upside: +441.46%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $6.28
Upside: +298.41%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $0.83
Upside: +863.86%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.60
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.67
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $36.68
Upside: +49.95%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $9.13
Upside: +458.60%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $3.29
Upside: +112.77%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $4.35
Upside: +1,187.36%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $9.84
Upside: +215.04%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $1.02
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $28
Current: $0.31
Upside: +8,848.55%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $21.64
Upside: +38.63%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.05
Upside: +1,048.33%